Substituted triazole derivatives as oxytocin antagonists

Details for Australian Patent Application No. 2006207300 (hide)

Owner Pfizer Limited

Inventors Brown, Alan Daniel; Ellis, David; Calabrese, Andrew Antony

Agent Allens Arthur Robinson

Pub. Number AU-B-2006207300

PCT Pub. Number WO2006/077496

Priority 0501190.3 20.01.05 GB

Filing date 11 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 3 March 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/077496 Priority application(s): WO2006/077496

3 March 2011 Application Accepted

  Published as AU-B-2006207300

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207308-Polypeptide mutagenesis method

2006207286-A sealing element and a coupling device provided with such a sealing element